To the editor:
Chimerism levels after stem cell transplantation are primarily determined by the ratio of donor to host stem cells Ever since the concept of the hematopoietic stem cell (HSC) niche was first proposed in 1978, there has been debate whether toxic ablative conditioning is required before transplantation for creating HSC niche space, or whether engraftment is merely determined by stem cell competition between donor and host stem cells. Two recent studies describe low chimerism levels after transplanting high doses of purified HSCs in unconditioned hosts 1,2 and attribute this poor engraftment to limited HSC niche spaces. This shows that in more than 30 years of research, the issue of HSC niche availability as a prerequisite for substantial chimerism has not been settled.
We directly addressed this issue in 2 different dose-response experimental models. In a congenic parent-into-F1 model, we transplanted 10 ϫ 10 6 , 30 ϫ 10 6 , and 100 ϫ 10 6 unfractionated C57BL/6 CD45.1 bone marrow cells (BMCs) into unconditioned C57BL/6 CD45.1 ϫ CD45.2 F1 recipient mice. Peripheral blood granulocytes (Gr-1 ϩ ) 16 weeks after transplantation demonstrated dose-dependent chimerism levels of 4.3% (Ϯ 1.7%), 8.9% (Ϯ 2.5%), and 23.2% (Ϯ 8.5%), respectively. Given that the bone marrow compartment of adult mice contains approximately 300 ϫ 10 6 BMCs, 3 these results are remarkably concordant with the theoretical maximum chimerism of 3%, 9%, and 25%, respectively. In the other type of model, we transplanted 10 ϫ 10 6 , 30 ϫ 10 6 , and 100 ϫ 10 6 unfractionated CD45.2 BMCs into anti-CD40-Ligand treated CD45.1 recipient mice and determined chimerism levels 20 weeks after transplantation in the peripheral blood Gr-1 ϩ population and in the c-Kit hi /Lin Ϫ /Sca-1 ϩ (KLS) population in the bone marrow, which is highly enriched for HSCs. Anti-CD40-ligand treatment served to prevent rejection resulting from CD45 polymorphism. Gr-1 ϩ chimerism levels showed a similar linear relation to the number of BMCs transplanted as in the parent-into-F1 model. Moreover, a linear relation was also observed in the bone marrow KLS fraction ( Figure  1A ). These data show that even after transplantation of very high doses BMCs (100 ϫ 10 6 ), the majority of donor HSC indeed engraft. In a subsequent experiment, we assessed donor chimerism in the more primitive KLS/CD34 Ϫ BMC population, containing the HSC fraction. Twenty weeks after transplanting 100 ϫ 10 6 unfractionated CD45.2 BMCs into unconditioned CD45.1 mice, we detected similar high levels of donor chimerism within the Gr-1 ϩ , the KLS BMC population, and the KLS/CD34 Ϫ BMC population ( Figure 1B) .
We previously reported similar findings after transplanting high doses of BMCs in a hybrid resistance model 4 and in a major mismatched setting after immunologic conditioning, 5 indicating that our findings are not model-dependent.
Our data show that high levels of engraftment can be obtained without myeloablation and importantly show that the availability of niche space is not a limiting factor in HSC engraftment. The linear relationship between engraftment and donor to host stem cells ratios may be lost on the use of enriched or purified populations of stem cells, underscoring the important role of accessory cells. This may explain why this issue remained unresolved for such a long time. We conclude that strategies aimed at enhancing donor 
